Biography

Tom represents clients in a wide range of corporate matters, including debt and equity financings, mergers & acquisitions, corporate governance and contract negotiations, with a particular focus on advising companies and investment funds in venture capital transactions. Tom has extensive experience working with all types of companies at all stages of development.

Select Representative Matters

Venture Capital

  • Represented various companies in numerous $2-10 million early stage (i.e., Series Seed and Series A) venture capital financings.
  • Represented a biotechnology company in its $6.5 million Series A venture capital financing that included a conversion of the company’s business structure from a Delaware limited liability company to a Delaware corporation via statutory conversion.
  • Represented a medical device company in its $8 million Series B venture capital financing that included a reincorporation of the company from Minnesota to Delaware.
  • Represented a medical device company in its $35 million Series B venture capital financing.
  • Represented a genetic counseling company in its $8 million Series C venture capital financing that included a conversion of the company’s business structure from a limited liability company to a corporation via a contribution and exchange transaction and a reorganization of the company’s ownership structure.
  • Represented an investment fund in a $28 million Series C venture capital financing.
  • Represented a biotechnology company in its $47 million Series C venture capital financing and its subsequent $40 million Series C-1 extension.
  • Represented a medical device company in its $75 million Series E venture capital financing.

Mergers & Acquisitions

  • Represented a venture-backed pharmaceutical company in a merger transaction in which a global pharmaceutical company provided $2 million in venture financing and secured an exclusive option to acquire the venture-backed pharmaceutical company for up to $48 million plus additional milestone payments.
  • Represented a medical device company in its $70 million strategic acquisition by a global medical company.
  • Represented a medical device company in its $72 million acquisition by a European medical device manufacturing company.
  • Represented a medical device company in its $102 million acquisition by a Japanese company.
  • Represented a venture-backed medical device company in its acquisition by a global medical technology company for $75 million in cash and up to an additional $50 million in subsequent earn-out payments.
  • Represented a technology and computer hardware company in its acquisition by a direct competitor for $115 million in cash and equity.

Asset Sales

  • Represented a medical device company in the sale of a product line to another medical device company for $5 million.
  • Represented a medical device company in the sale of a product line to a medical device and manufacturing company for $20 million.

Securities and Capital Markets

  • Represented a biopharmaceutical company in its $16 million US underwritten public offering.

Before Fox Rothschild

Prior to joining Fox, Tom was an attorney at a Wisconsin-based law firm.

During law school, Tom worked in the University of Minnesota Law School’s Housing Clinic and Ronald M. Mankoff Tax Clinic, first as a student attorney and the following year as a director. Tom was also a judicial extern to the Honorable Gina M. Brandt of the Hennepin County District Court.